Endocyte

PSMA-617-01

NCT03511664

PSMA-617-01

Study of 177Lu-PSMA-617 in Metastatic Castrate-Resistant Prostate Cancer (VISION)

Status:

Closed to Accrual

26459-200.png

III

Phase

Line of Therapy.png

2nd+

Line of Therapy

Disease Stage.png

Advanced / Metastatic

Disease Stage

Target.png

Biomarker(s)

N/A

Investigational

Product

177Lu-PSMA-617

Radioligand therapy (RLT) (i.v.)

Treatment Arms

o Experimental: 177Lu-PSMA-617 plus BS/BSC

o BS/BSC alone